← 홈

CGT

253개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-14 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 253개
CGTSHOTFDACuratedFDABiologicFerring PharmaceuticalsHuman interferon alfa-2bApproved

nadofaragene firadenovec (Adstiladrin, rAd-IFNα/Syn3, nadofaragene firadenovec-vncg)

High-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) · IFNα2b (adenoviral)

#IFN2badenoviral#CGT#Approved#FDA승인#바이오모아추천+5
효능 ORR 55%임상시험 10상태 APPROVED
CGTABiologicJanssen Research & Development,…Phase 3

AA (Abiraterone acetate, Abiraterone acetate (AA))

Metastatic Castration-sensitive Prostate Cancer · Metastatic Castration-sensitive Prostate

#MetastaticCastration-sensitivePr#CGT#Phase3#인기#세포유전치료+3
효능 ORR 57.1%임상시험 77상태 RECRUITING
CGTABiologicNational Cancer Institute (NCI)inPhase 1

Anti-B Cell Maturation Antigen (BCMA, Anti-B Cell Maturation Antigen, Anti-B Cell Maturation Antigen (BCMA) chimeric antigen receptors (CARs) T cells)

Myeloma-Multiple; Myeloma, Plasma-Cell · BCMA

#BCMA#CGT#Phase1#인기#세포유전치료+5
효능 ORR 97.1%임상시험 73상태 RECRUITING
CGTBiologicHoffmann-La RochePhase 1

Interferon-Alfa-2b (Interferon-Alfa-2b)

Solid Cancers · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase1#인기#세포유전치료+5
효능 ORR 24%임상시험 63상태 ACTIVE
CGTBiologicBeijing Geekgene Technology Co.…Preclinical

TCR-T cells (TCR-T cells)

Gastric Cancer; Esophageal Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 50%임상시험 63상태 RECRUITING
CGTBiologicShanghai Unicar-Therapy Bio-med…Phase 1

chimeric antigen receptor T cell (chimeric antigen receptor T cell)

Pancreatic Cancer; CAR · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 67%임상시험 62상태 ACTIVE
CGTBiologicAlliance for Clinical Trials in…Phase 3

Allopurinol (Allopurinol)

B Acute Lymphoblastic Leukemia · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase3#인기#세포유전치료+5
임상시험 61상태 DISCONTINUED
CGTBiologicGlaxoSmithKlineSN-38 also augmented IL-10 …Phase 2

topotecan hydrochloride (topotecan hydrochloride)

Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 95.4%임상시험 61상태 DISCONTINUED
CGTBiologicEpicentRx, Inc.Phase 2

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Solid Tumor, Adult; Cancer · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase2#인기#세포유전치료+5
효능 ORR 59%임상시험 60상태 RECRUITING
CGTBiologicMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
효능 0%임상시험 60상태 DISCONTINUED
CGTBiologicSabz BiomedicalsPhase 2

cytokine-induced killer cell (cytokine-induced killer cell)

Colon Cancer Stage IV · Solid Tumors

#SolidTumors#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 ACTIVE
CGTBiologicGamma Medica-IdeasPhase 2

tamoxifen citrate (tamoxifen citrate)

Male Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 13%임상시험 60상태 ACTIVE
CGTBiologicImmunityBio, Inc.sPhase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#인기#세포유전치료+4
임상시험 59상태 DISCONTINUED
CGTBiologicSPP Pharmaclon Ltd.Phase 2

Recombinant Interferon Alfa (Recombinant Interferon Alfa)

Colorectal Cancer; Kidney Cancer · Bladder Cancer

#BladderCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 32.4%임상시험 59상태 ACTIVE
CGTBiologicSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#인기#세포유전치료+4
효능 ORR 42%임상시험 58상태 ACTIVE
CGTBiologicCalimmune, Inc.Phase 1

Gene Modified T Cells (Gene Modified T Cells)

Prostate Cancer · Prostate Cancer

#ProstateCancer#CGT#Phase1#인기#세포유전치료+4
효능 ORR 92.9%임상시험 58상태 DISCONTINUED
CGTBiologicCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Fallopian Tube Cancer; Ovarian Cancer · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 5%임상시험 57상태 DISCONTINUED
CGTBiologicImmunityBio, Inc.vedotin (BT8009) and dual-A…Phase 2

IL-15 Superagonist (N-803, N-803 (IL-15 Superagonist))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80%임상시험 57상태 DISCONTINUED
CGTBiologicShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#인기#세포유전치료+4
임상시험 54상태 ACTIVE
CGTBiologicNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 ACTIVE

1 / 13 페이지

← 이전다음 →